Featuring A. Trevor Thrall, Associate Professor, School of Policy, Government, and International Affairs, George Mason University; and Erik Goepner, Doctoral student in public policy, George Mason University; with comments by Betsy Woodruff, Politics Reporter, The Daily Beast; Emily Ekins, Research Fellow, Cato Institute; and Aaron Schumacher, Director, International, Foreign Policy Group, and Senior Vice President, Young Professionals in Foreign Policy; moderated by Christopher Preble, Vice President for Defense and Foreign Policy Studies, Cato Institute.
A limited constitutional government calls for a rules-based, freemarket monetary system, not the topsy-turvy fiat dollar that now exists under central banking. This issue of the Cato Journal examines the case for alternatives to central banking and the reforms needed to move toward free-market money.
Americans are finally enjoying an improving economy after years of recession and slow growth. The unemployment rate is dropping, the economy is expanding, and public confidence is rising. Surely our economic crisis is behind us. Or is it? In Going for Broke: Deficits, Debt, and the Entitlement Crisis, Cato scholar Michael D. Tanner examines the growing national debt and its dire implications for our future and explains why a looming financial meltdown may be far worse than anyone expects.
The Cato Institute has released its 2014 Annual Report, which documents a dynamic year of growth and productivity. “Libertarianism is not just a framework for utopia,” Cato’s David Boaz writes in his book, The Libertarian Mind. “It is the indispensable framework for the future.” And as the new report demonstrates, the Cato Institute, thanks largely to the generosity of our Sponsors, is leading the charge to apply this framework across the policy spectrum.
Resolved: Congress Should Remove the Ban on Drug Reimportation
In the affirmative, Roger Pilon,
Vice President for Legal Affairs, Cato Institute; in the negative, John E. Calfee,
Resident Scholar, American Enterprise Institute.
In this election year, the drug reimportation debate is heating up. Last year the House easily passed a bill that would allow Americans to buy prescription drugs abroad, where they sell at far below American prices, but the bill stalled in the Senate. This year pressure is building from governors, mayors, and ordinary citizens, many of whom are simply ignoring the current ban on importing drugs. Proponents of the bill say that free trade is likely to reduce the high prices Americans now pay for prescription drugs. Opponents raise safety concerns and add that the bill would amount to importing foreign price controls. Please join us for a timely debate on an issue that touches millions of Americans.